Herceptin Biosimilar for Breast Cancer Now Available in US

Moderators
Moderators Member Posts: 25,912

Herceptin Biosimilar for Breast Cancer Now Available in U.S. Market
July 24, 2019

Kanjinti (trastuzumab-anns), a biosimilar for Herceptin used to treat people diagnosed with HER2-positive breast cancer, is now available in the United States. Read more...

Categories